The company, which focuses on developing exoskeletons, plans to list on the NASDAQ under the symbol RWLK. Barclays and Jefferies acted as joint bookrunners on the deal, according to the report.
More articles on devices:
LifeScience Alley honors Zimmer’s Virage OCT Spinal Fusion System
5 key concepts on Zyga Technology’s $10M financing
Stryker looks to expand facility
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
